A
ACAD
Acadia Pharmaceuticals Inc
21.16
+0.06+0.28%Opening13:17 05/26 EDT
OPEN/PREV CLOSE21.07/21.10
TODAY RANGE20.91-21.27
VOL50
MARKET CAP3.64B
52 WEEK RANGE19.69-28.35
AVG VOL (3M)1.85M
% TURNOVER0.56%
TURNOVER0
P/E (TTM)9.71
% RANGE1.66%
EPS(TTM)2.188
P/E(FORWARD)57.46
P/B2.914
BVPS7.30
DIVIDEND--
P/S3.379
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.60B
SHARES OUTSTANDING171.24M
NEXT EARNINGS08/04-08/10
FREE FLOAT169.21M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6d ago
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Pipeline Progress And Product Rollouts
Simply Wall St·05/17 04:37
How ACADIA’s (ACAD) Solid Q1 Revenue and Pipeline Update Has Changed Its Investment Story
Seeking Alpha·05/14 18:40
Biopharmas look to China, elsewhere for partnerships, R&D
TipRanks·05/11 12:05
BMO Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)
Simply Wall St·05/10 22:21
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Mixed Q1 2026 Results And EU Trofinetide Setback
Simply Wall St·05/08 22:00
Acadia Pharmaceuticals (ACAD) Margin Expansion To 34.3% Tests Bearish Growth Concerns
Dow Jones·05/08 20:52
ACADIA Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones·05/08 20:52
ACADIA Pharmaceuticals Price Target Cut to $32.00/Share From $33.00 by Citigroup
Benzinga·05/08 20:43
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $32
TipRanks·05/08 11:44
Guggenheim Keeps Their Hold Rating on ACADIA Pharmaceuticals (ACAD)
TipRanks·05/08 11:24
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
TipRanks·05/08 02:07
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call
Same Industry
Name/Symbol
Change%
Price